Unknown

Dataset Information

0

Loss of CMTM6 promotes DNA damage-induced cellular senescence and antitumor immunity.


ABSTRACT: Recent studies have revealed that chemokine-like factor-like MARVEL transmembrane domain-containing family member 6 (CMTM6) promotes tumor progression and modulates tumor immunity by regulating programmed death-ligand 1 stability; however, its intrinsic functions and regulatory mechanisms in clear cell renal cell carcinoma (ccRCC) remain poorly understood. Here, we show that CMTM6 is upregulated in ccRCC tissues and is strongly associated with advanced tumor grades, early metastases, and a worse prognosis. CMTM6 depletion significantly impaired the proliferation, migration, and invasion of ccRCC cells in vitro and in xenograft mouse models in vivo. In addition, targeting CMTM6 promotes anti-tumor immunity, represented by increased infiltration of CD4+ and CD8+ T cells in syngeneic graft mouse models. Further research revealed that loss of CMTM6 triggered aberrant activation of DNA damage response, resulting in micronucleus formation and G2/M checkpoint arrest, finally leading to cellular senescence with robust upregulation of numerous chemokines and cytokines. Our findings show for the first time the novel role of CMTM6 in maintaining cancer genome stability and facilitating tumor-mediated immunosuppression, linking DNA damage signaling to the secretion of inflammatory factors. Targeting CMTM6 may improve the treatment of patients with advanced ccRCC.

SUBMITTER: Wang H 

PROVIDER: S-EPMC8747516 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC9135943 | biostudies-literature
| S-EPMC7614152 | biostudies-literature
| S-EPMC5828632 | biostudies-literature
| S-EPMC2118600 | biostudies-literature
| S-EPMC5737622 | biostudies-literature
| S-EPMC4426031 | biostudies-literature
| S-EPMC6203593 | biostudies-literature
| S-EPMC5100879 | biostudies-literature
| S-EPMC4871470 | biostudies-literature
| S-EPMC5418196 | biostudies-literature